We’re wearing red today to help raise awareness for women’s cardiovascular health. ❤️ #GoRedBSC

“2025 was another exceptional year for Boston Scientific, with our global teams delivering differentiated innovation and high performance that enabled us to exceed our goals," says CEO Mike Mahoney. Here are key takeaways from our earnings announcement: news.bostonscientific.com/nterested-in...

Boston Scientific announces results for Q4 and Full Year 2025: news.bostonscientific.com/2026-02-04-B...

Our Neuromodulation business is dedicated to developing minimally invasive therapies and technologies that help patients manage debilitating chronic pain and movement disorders. Meet our new chief medical officer, Neuromodulation, Scott Kreiner, MD: news.bostonscientific.com/a-passion-fo...

After receiving the WATCHMAN Left Atrial Appendage Closure device to reduce stroke risk, Laine's dad was able to celebrate her wedding and look forward to more family celebrations. “I don’t even know what life would look like without WATCHMAN,” says Laine. spklr.io/63326BzZDw

Here are a few key takeaways from our earnings announcement: news.bostonscientific.com/interested-i...

Boston Scientific announces results for Q3 2025: news.bostonscientific.com/2025-10-22-B...

Read about the U.S. launch of the AGENT™ Drug Coated Balloon: spklr.io/63324BKJ8m @wallstreetjournal.bsky.social #CardioSky #MedSky

It's Liver Cancer Awareness Month! Your liver: • Is about the size of an American football • Weighs ~3 pounds • Has the important job of processing nutrients in your blood and filtering out toxins Learn more the therapies available to kill liver cancer: spklr.io/63325BJhLz

At our 2025 Investor Day, we shared how relentless innovation fuels sustainable growth. 📈 Organic sales continue to outpace the market 🔬 Clinically differentiated launches strengthen category leadership 🚀 Investing in high-growth markets with a durable, best-in-class pipeline through 2030+

Here are a few key takeaways from our earnings announcement: news.bostonscientific.com/interested-i...

Boston Scientific announces results for Q2 2025: news.bostonscientific.com/2025-07-23-B...

A recent article in Investor's Business Daily highlights how our CEO, Mike Mahoney, has helped shape Boston Scientific's winning culture. Under his leadership, we remain committed to advancing science for more than 44 million patients worldwide. #AdvancingTogether www.investors.com/news/managem...

Carotid artery disease is one of the leading causes of stroke. In recognition of #StrokeAwarenessMonth, learn how an innovative technology called #TCAR could help millions of people each year: news.bostonscientific.com/4-things-to-...

AI-powered algorithms are enabling earlier diagnoses, simplifying treatment decisions, and helping predict and prevent medical emergencies. In @wsj.com, read Senior VP & Global Chief Medical Officer Ken Stein on 3 ways we’re already using AI to improve patient care: partners.wsj.com/boston-scien...

This morning, we announced our Q1 2025 earnings. Here are a few key takeaways: news.bostonscientific.com/interested-i...

In honor of #MinorityHealthMonth, watch Senior Vice President & Global Chief Medical Officer Kenneth Stein speak from the New York Stock Exchange about Close the Gap, our 20+ year effort to reduce barriers to therapies that can make a difference. 🤝 @nycrhythmdoc.bsky.social #Medsky

We have successfully closed the acquisition of Bolt Medical. We look forward to advancing the intravascular lithotripsy (IVL) therapy developed by Bolt which will complement our cardiovascular portfolio by expanding treatment options for coronary and peripheral disease. $BSX

Further expansion of our cardiovascular portfolio includes today’s announcement that we’ve agreed to acquire SoniVie, developer of an intravascular ultrasound system designed to perform renal artery denervation for the treatment of hypertension. #Medsky news.bostonscientific.com/2025-03-03-B...

“Everything we do is about making sure we advance care for patients around the world suffering from urological conditions,” says Meghan Scanlon, SVP and president, Urology. She shares how our acquisition of Axonics, Inc. will help us do just that. news.bostonscientific.com/4-things-to-... #Medsky

Check out a few key takeaways from our most recent earnings announcement: news.bostonscientific.com/interested-i...

Hello, Bluesky! We're excited to join the #medtech community here. 🔬 We're a global company dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Learn more and stay up to date on our latest news at news.bostonscientific.com.